Skip to main content
. 2024 Apr 9;21(6):1114–1121. doi: 10.1038/s41592-024-02241-6

Extended Data Fig. 4. Plate maps and overview of compounds’ clinical phase status.

Extended Data Fig. 4

Maps in a-c show a) Compound plate, b) CRISPR plate and c) ORF plate. The control wells and the treatment (trt) wells are shown in different colors. Poscon are positive controls (additional details in the Methods section) and negcon is the negative control. d) Over a third of the compounds in the dataset have been launched for sale, whereas others have progressed to various stages of human clinical trials.